XXXIst diabetes days with international participation

Czech version

Authors: Peter Novodvorský ^1,2,3
Authors‘ workplace: metabolické centrum s. r. o., Trenčín ¹; Centrum diabetologie IKEM, Praha ²; Department of Oncology and Metabolism, Medical School, University of Sheffield, United Kingdom ³
Published in: Diab Obez 2021; 21(42): 109-110
Category: News

Labels

Diabetology Obesitology

Slovak diabetology – history, contemporary and future

New possibility in therapy of diabetes mellitus: co-formulation of insulin degludec and insulin aspart

Compensation of social consequences of diabetes mellitus

News in the field of SGLT2 inhibitors

Interesting (and not much discussed) aspects relevant for the choice of basal insulin

GLP-1 receptors treatment: case reports

Tortuous path of insulin discovery

Report from the Symposium on technology in diabetology in Slovakia

81. virtual conference of American Diabetes Association 2021

What is the message of the virtual European Congress of Cardiology in August 2021 on the role of new antidiabetic drugs in the treatment of heart failure?

Article was published in

Diabetes and obesity

2021 Issue 42